268 related articles for article (PubMed ID: 31593656)
1. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
Hattori A; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
[TBL] [Abstract][Full Text] [Related]
2. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
[TBL] [Abstract][Full Text] [Related]
3. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer.
Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K
Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328
[No Abstract] [Full Text] [Related]
10. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
[TBL] [Abstract][Full Text] [Related]
11. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
12. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219
[TBL] [Abstract][Full Text] [Related]
13. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
15. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity.
Iwata H; Shirahashi K; Mizuno Y; Yamamoto H; Takemura H
Eur J Cardiothorac Surg; 2014 Sep; 46(3):375-9; discussion 379. PubMed ID: 24562008
[TBL] [Abstract][Full Text] [Related]
18. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
[TBL] [Abstract][Full Text] [Related]
19. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
